Tunable Stent for Cerebrospinal Venous Insufficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods and devices are not optimal for treating chronic cerebrospinal venous insufficiency (CCVI) in multiple sclerosis patients, as they lack proper size, length, and functional characteristics, leading to risks such as stent displacement, migration, and re-stenosis, and existing venous stents are not specifically designed for the internal jugular or azygous veins.
Innovation Solution
Development of endovascular and exovascular devices with tunable stents that can be constrained, self-expand, and further pressure-expand to match the anatomy of stenotic veins, including self-expanding components and plastically deformable constraining members, to ensure proper anchoring and prevent migration, along with methods for customizing and adjusting the devices based on individual vein measurements and anatomy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If existing venous stents are used for treating CCVI, then the treatment can be provided, but the stents are not properly sized and shaped for the internal jugular or azygous veins, leading to displacement and migration
Solution Approach 1:
The stent is designed with varying properties along its length to match the specific anatomy of the internal jugular or azygous veins. Different sections of the stent have different expansion ratios, flexibilities, and radial strengths to accommodate the natural curvature and diameter variations of the target vein, preventing displacement and migration while maintaining reliability
Solution Approach 2:
The stent incorporates dynamic characteristics that allow it to adapt to physiological movements and changes in vein diameter. The stent can flex and conform to the natural movements of the neck and thoracic cavity, maintaining stable anchoring while accommodating changes in venous pressure and flow conditions
2Ease of manufacture
If conventional angioplasty techniques are used, then the procedure can be performed, but the stents lack proper size and length, causing re-stenosis
Solution Approach 1:
The stent manufacturing process allows for customization of key parameters including length, diameter, expansion ratio, and flexibility to match the specific anatomy of each patient's internal jugular or azygous veins. This enables precise fitting to the patient's unique vascular geometry, preventing re-stenosis while maintaining ease of manufacture through standardized customization protocols
3Device complexity
If standard stents are used, then the treatment is simpler, but the stents may displace or migrate due to lack of proper anchoring
Solution Approach 1:
The stent design incorporates asymmetric features such as directional barbs, uneven expansion patterns, or asymmetric anchoring elements that provide secure fixation in the vein. These asymmetric characteristics prevent the stent from migrating or displacing while maintaining relatively simple overall design and ease of deployment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution effectively improves blood flow by equalizing pressure upstream and downstream of stenotic regions, reducing the risk of re-stenosis and migration, and providing a secure fit within the veins, thus addressing the limitations of existing treatments for CCVI.
Implementation Method 1
comprises at least one self-expanding stent member
Implementation Method 2
at least one plastically deformable constraining member connected to the at least one self-expanding stent member
Data Source
AI summary
Methods and devices for relieving stenoses in, or otherwise improving blood flow through, body lumens. Although applicable in a variety of different body lumens, the methods and devices of this invention are specifically useable for relieving stenoses in, or otherwise improving blood flow through, veins which drain blood from the brain for treatment of multiple sclerosis or other neurodegenerative disorders that are caused, triggered or exacerbated by venous occlusion or venous insufficiency.


